ResearcherZhengzhou UniversityNo recent work listed
Bo Meng
Matched on ORCID iD 0000-0003-0433-5038; OpenAlex author ID A5061334968. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc. Co-author DOI 10.3892/ijo.2022.5456↗
- LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p/HOXB8 axis. Co-author DOI 10.1186/s12935-019-1036-2↗
- Several genes involved in the JAK-STAT pathway may act as prognostic markers in pancreatic cancer identified by microarray data analysis. Last author DOI 10.1097/md.0000000000013297↗
- MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells. Co-author PMID 26261532↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yunjian Wang · 2 shared papers, 2019–2023 · strength 0.29
- Luyang Zhang · 2 shared papers, 2019–2023 · strength 0.29
- Qiong Li · 1 shared paper, 2023 · strength 0.18
- Min Zhang · 1 shared paper, 2023 · strength 0.18
- Enze Wang · 1 shared paper, 2023 · strength 0.18
- Yuechao Ding · 2 shared papers, 2015–2018 · strength 0.15
- Paper Several genes involved in the JAK-STAT pathway may act as prognostic markers in pancreatic cancer identified by microar… DOI 10.1097/md.0000000000013297↗
- Paper MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem ce… PMID 26261532↗
- Min Zhang · 1 shared paper, 2019 · strength 0.10
- Ling Zhang · 1 shared paper, 2019 · strength 0.10
- Chun Pang · 1 shared paper, 2018 · strength 0.09
- Suxia Luo · 1 shared paper, 2015 · strength 0.06
- Chao Ma · 1 shared paper, 2015 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.